Botulinum toxin type A injection in the treatment of lichen simplex: An open pilot study

Journal of the American Academy of Dermatology

Volumn 46, Issue 4, 2002, Pages 617-619

  Heckmann, Marc ^a   Heyer, Gisela ^b   Brunner, Birgit ^a   Plewig, Gerd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; CORTICOSTEROID; TOPICAL AGENT;

ACETYLCHOLINE RELEASE; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; DRUG EFFECT; FOLLOW UP; HUMAN; NEURODERMATITIS; PRIORITY JOURNAL; PRURITUS;

EID: 0036553463     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120455     Document Type: Article

References (21)

1. Singh G. Atopy in lichen simplex (neurodermatitis circumscripta). Br J Dermatol 1973;89:625-7.
2. Burton JL. Eczema, lichenification, prurigo and erythroderma. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL, editors. Textbook of dermatology. 5th ed. Oxford (UK): Blackwell Scientific Publications; 1992. p. 537-88.
3. Schmelz M, Schmidt R, Bickel A, Handwerker HO,Torebjork HE. Specific C-receptors for itch in human skin. J Neurosci 1997;17: 8003-8.
4. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43:249-59.
5. Hallett M. How does botulinum toxin work? Ann Neurol 2000; 48:7-8.
6. Bushara KO, Park DM, Jones JC, Schutta HS. Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 1996;21:276-8.
7. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 1997;136:548-52.
8. Heckmann M, Schaller M, Plewig G, Ceballos-Baumann A. Optimizing botulinum toxin therapy for hyperhidrosis. Br J Dermatol 1998;138:553-4.
9. Shelley WB,Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol 1998;38:227-9.
10. Heckmann M, Breit S, Ceballos BA, Schaller M, Plewig G. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol 1999;41:987-90.
11. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin [see comments].Arch Dermatol 1998; 134:301-4.
12. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg 1998;24:817-9.
13. Heyer G, Ulmer FJ, Schmitz J, Handwerker HO. Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. Acta Derm Venereol 1995;75:348-52.
14. Heyer GR, Hornstein OP. Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 1999;26:77-86.
15. Heyer G, Vogelgsang M, Hornstein OP. Acetylcholine is an inducer of itching in patients with atopic eczema. J Dermatol 1997; 24:621-5.
16. Ishikawa H, Mitsui Y, Yoshitomi T, Mashimo K, Aoki S, Mukuno K, et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 2000;44:106-9.
17. Purkiss J, Welch M, Doward S, Foster K. Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 2000;59:1403-6.
18. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85: 101-5.
19. Rollnik JD,Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000;40:300-5.
20. Oguma K, Fujinaga Y, Inoue K. Structure and function of Clostridium botulinum toxins. Microbiol Immunol 1995;39: 161-8.
21. Braune C, Erbguth F, Birklein F. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry. Br J Dermatol 2001;144:111-7.